Search research articles
Contact Us
Filters
Showing results (181-190 of 272) with videos related to
Page
of 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2009
Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial
Emanuela Rossi, Alessandro Morabito, Francesca Di Rella, et al.
Oncology
|
September 20, 2007
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study
Sandro Pignata, Gabriella Ferrandina, Giovanna Scarfone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2003
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group
Cesare Gridelli, Ciro Gallo, Frances A Shepherd, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 27, 2025
The impact of body mass index on survival and surgical outcomes in ovarian cancer: insights from the MITO trials
Teresa Di Lauro, Ilaria De Benedictis, Paolo Chiodini, et al.
Exploration of Targeted Anti-Tumor Therapy
|
September 1, 2022
Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
Giuliano Palumbo, Giovanna Esposito, Guido Carillio, et al.
The Lancet. Oncology
|
September 1, 2005
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials
Massimo Di Maio, Cesare Gridelli, Ciro Gallo, et al.
BMC Cancer
|
February 18, 2011
Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial
Francesco Nuzzo, Alessandro Morabito, Adriano Gravina, et al.
Thescientificworldjournal
|
June 2, 2012
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients
Simona Signoriello, Annalisa Annunziata, Nicola Lama, et al.
Cancers
|
March 13, 2019
The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients
Anna Maria Rachiglio, Francesca Fenizia, Maria Carmela Piccirillo, et al.
The Lancet Regional Health. Europe
|
July 22, 2024
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
Page
of 28
Search research articles
Search
Showing results (181-190 of 272) with videos related to
Sort By:
Page
of 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2009
Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial
Emanuela Rossi, Alessandro Morabito, Francesca Di Rella, et al.
Oncology
|
September 20, 2007
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study
Sandro Pignata, Gabriella Ferrandina, Giovanna Scarfone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2003
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group
Cesare Gridelli, Ciro Gallo, Frances A Shepherd, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 27, 2025
The impact of body mass index on survival and surgical outcomes in ovarian cancer: insights from the MITO trials
Teresa Di Lauro, Ilaria De Benedictis, Paolo Chiodini, et al.
Exploration of Targeted Anti-Tumor Therapy
|
September 1, 2022
Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
Giuliano Palumbo, Giovanna Esposito, Guido Carillio, et al.
The Lancet. Oncology
|
September 1, 2005
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials
Massimo Di Maio, Cesare Gridelli, Ciro Gallo, et al.
BMC Cancer
|
February 18, 2011
Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial
Francesco Nuzzo, Alessandro Morabito, Adriano Gravina, et al.
Thescientificworldjournal
|
June 2, 2012
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients
Simona Signoriello, Annalisa Annunziata, Nicola Lama, et al.
Cancers
|
March 13, 2019
The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients
Anna Maria Rachiglio, Francesca Fenizia, Maria Carmela Piccirillo, et al.
The Lancet Regional Health. Europe
|
July 22, 2024
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
Page
of 28